Page last updated: 2024-09-02

tadalafil and testosterone enanthate

tadalafil has been researched along with testosterone enanthate in 2 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(testosterone enanthate)
Trials
(testosterone enanthate)
Recent Studies (post-2010) (testosterone enanthate)
1,7423921,089570143116

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, JH; Kim, JJ; Kim, JW; Moon, DG; Oh, MM; Park, JY; Park, MG1
Abbaszadeh Hasiri, M; Ahrari Khafi, MS; Dearakhshandeh, N; Golchin-Rad, K; Mogheiseh, A; Nazifi, S1

Trials

1 trial(s) available for tadalafil and testosterone enanthate

ArticleYear
Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil.
    Journal of veterinary pharmacology and therapeutics, 2019, Volume: 42, Issue:6

    Topics: Androgens; Animals; Contraceptive Agents, Hormonal; Dog Diseases; Dogs; Estradiol; Gene Expression Regulation; Inflammation; Male; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Testosterone

2019

Other Studies

1 other study(ies) available for tadalafil and testosterone enanthate

ArticleYear
Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency.
    International journal of impotence research, 2013, Volume: 25, Issue:1

    Topics: Adult; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Retreatment; Tadalafil; Testosterone; Treatment Outcome; Vasodilator Agents

2013